Wall Street Zen cut shares of MetLife (NYSE:MET - Free Report) from a buy rating to a hold rating in a research report report published on Saturday morning.
Several other analysts have also issued reports on MET. JPMorgan Chase & Co. lowered their price target on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 2nd. Wells Fargo & Company increased their target price on shares of MetLife from $91.00 to $94.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. Barclays lowered their target price on shares of MetLife from $95.00 to $88.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Piper Sandler increased their target price on shares of MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Finally, UBS Group increased their target price on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research note on Wednesday, April 2nd. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, MetLife currently has an average rating of "Moderate Buy" and an average price target of $94.17.
Read Our Latest Report on MET
MetLife Stock Performance
Shares of NYSE MET traded up $1.78 during midday trading on Friday, hitting $78.99. The company's stock had a trading volume of 3,300,569 shares, compared to its average volume of 3,402,354. The stock has a fifty day moving average price of $76.77 and a 200 day moving average price of $81.08. MetLife has a one year low of $65.21 and a one year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $53.03 billion, a price-to-earnings ratio of 13.23, a P/E/G ratio of 0.65 and a beta of 0.85.
MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.00 by ($0.04). MetLife had a net margin of 6.19% and a return on equity of 20.42%. The business had revenue of $18.57 billion during the quarter, compared to the consensus estimate of $18.06 billion. During the same period last year, the firm earned $1.83 EPS. The business's revenue for the quarter was up 15.6% on a year-over-year basis. On average, research analysts forecast that MetLife will post 9.65 EPS for the current fiscal year.
MetLife Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th will be issued a dividend of $0.5675 per share. The ex-dividend date is Tuesday, May 6th. This represents a $2.27 annualized dividend and a dividend yield of 2.87%. This is a positive change from MetLife's previous quarterly dividend of $0.55. MetLife's dividend payout ratio (DPR) is currently 36.91%.
MetLife declared that its board has approved a stock buyback plan on Wednesday, April 30th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to reacquire up to 5.9% of its shares through open market purchases. Shares buyback plans are often an indication that the company's board believes its shares are undervalued.
Institutional Investors Weigh In On MetLife
A number of large investors have recently added to or reduced their stakes in MET. United Asset Strategies Inc. increased its stake in shares of MetLife by 1.1% during the 4th quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider's stock valued at $895,000 after acquiring an additional 120 shares during the last quarter. Barrett & Company Inc. increased its position in MetLife by 1.0% during the 4th quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider's stock worth $978,000 after purchasing an additional 121 shares in the last quarter. Eagle Strategies LLC increased its position in MetLife by 4.8% during the 4th quarter. Eagle Strategies LLC now owns 2,707 shares of the financial services provider's stock worth $222,000 after purchasing an additional 123 shares in the last quarter. J.W. Cole Advisors Inc. increased its position in MetLife by 2.1% during the 4th quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider's stock worth $495,000 after purchasing an additional 126 shares in the last quarter. Finally, Davis R M Inc. boosted its holdings in MetLife by 4.2% in the 4th quarter. Davis R M Inc. now owns 3,148 shares of the financial services provider's stock worth $258,000 after acquiring an additional 127 shares during the period. Institutional investors own 94.99% of the company's stock.
About MetLife
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.